Scientific Excellence
Unparalleled Experience
Superior Technology
Offering a Full Suite of Multi-Omic Services
The McDonnell Genome Institute has been at the forefront of genomics research since our central role in the Human Genome Project. Built to deliver results on time and on budget, MGI thrives on difficult projects.
Help Shape the 2024 Multi-Omic Fee-for-Service Report!
Participate in our survey and contribute to the inaugural 2024 Multi-omic Fee-for-Service Report. Share your insights and help define the trends driving the field.
Our High-Capacity Technology Hubs
Genome Technology Access Center
- Short-read sequencing
- Long-read sequencing
- High-throughput proteomics
- Single cell genomics
- Spatial transcriptomics
- Computational biology/bioinformatics
Genome Engineering & Stem Cell Center
- Genome-edited stem cell & cancer cell lines
- Genome-edited model organisms
- Patient-derived iPSCs
- Stem cell differentiation
- CRISPR screening
Mass Spectrometry Technology Access Center
- Proteomics
- Metabolomics
- Lipidomics
- Deep-scale PTM analysis
- Native Mass Spectrometry
- Spatial multi-omics MS technologies
Functional Imaging for Variant Elucidation
- Massively parallel genetic cellular screening
- Drug screening
- Isolating Live cells from Specific Phenotypes
- Spatial Transcriptomics Image Analysis
Built For Your Success
MGI is a world leader in genomics with a wide breadth of technologies and a rich history of collaborations through well-established sharing and outreach pipelines. Our work is particularly unique due to the breadth of resources we offer in one location.
16
Years MGI Employee Tenure
95%
% Repeat Partner Rate
65
Current Academic Institute Partners
56
Current Biopharma Partners
Regulatory Evolution in the Wild
When are Foundation Models Not the Answer?
